Magnetar Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-220,900
Closed -$27K 1165
2020
Q4
$27K Buy
220,900
+115,078
+109% +$4.22M ﹤0.01% 692
2020
Q3
$53K Buy
+105,822
New +$3.71M ﹤0.01% 635
2016
Q2
Sell
-1,054,000
Closed -$29.6M 448
2016
Q1
$29.6M Buy
1,054,000
+105,400
+11% +$3.01M 0.46% 57
2015
Q4
$29.1M Buy
+948,600
New +$29.8M 0.34% 58

Other funds holding PFE

Magnetar Financial's PFE Position: Q2 2025 in Review

Magnetar Financial sold out of Pfizer (PFE) in Q2 2025, closing a stake of 71,927 shares — an estimated $1.82M sold.

Magnetar Financial first reported a position in PFE in Q2 2013 and held it in 30 quarters. The position peaked at $83.8M in Q2 2013. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Magnetar Financial reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Magnetar Financial sold 71,927 Pfizer shares in Q2 2025, an estimated $1.82M.
  • Magnetar Financial first reported a position in Pfizer in Q2 2013 and held it in 30 quarters.
  • Magnetar Financial's Pfizer position peaked at $83.8M in Q2 2013.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Magnetar Financial's 13F filing for Q2 2025, filed 12 Aug 2025.